Sort
46,585 grants matching “heart failure”
Vascular Stiffness as a Precursor of Hypertension in a Middle-aged Cohort
$682,334Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2017 · HL
Exploration of Arrhythmogenic Triggers and Substrates in Heart Failure
$682,334Natalia A. Trayanova · Johns Hopkins University · R01 · FY2019 · HL
Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function
$682,305Christopher M Yengo · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · HL
Assessing feasibility and acceptability of a multifaceted EHR-integrated mobile health intervention following radical cystectomy
$682,272Tudor Borza · University Of Michigan At Ann Arbor · R34 · FY2025 · CA
Clinical and economic value of novel diabetes medications for prevention of cardiovascular disease in type 2 diabetes
$682,248Bart Ferket · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
Inverse neurovascular coupling in the hypothalamus and its role in positive feedback regulation of Vasopressin neurons in health and disease
$682,234Javier E Stern · Georgia State University · R01 · FY2022 · HL
Role of HIV gp120 and Nef in Transcriptome Dysregulation and Pulmonary Vascular Remodeling
$682,218Sharilyn Almodovar · Texas Tech University Health Scis Center · R01 · FY2025 · HL
Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury
$682,173Joachim H Ix · University Of California, San Diego · R01 · FY2023 · DK
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
$682,173Casey Crump · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
ENLACE: A Promotora-Led Physical Activity Intervention Trial for Latinas in Texas
$682,159Deborah M. Parra-Medina · University Of Texas Hlth Science Center · R01 · FY2014 · HL
Role of group 2 innate lymphoid cells in myocardial infarction
$682,143Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2022 · HL
Role of group 2 innate lymphoid cells in myocardial infarction
$682,143Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2023 · HL
Role of group 2 innate lymphoid cells in myocardial infarction
$682,143Peter Libby · Brigham And Women'S Hospital · R01 · FY2025 · HL
Optimizing Treatment of Lung Cancer Patients with Comorbidities
$682,087Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Patient Navigators: Secondary Prevention in Underserved Coronary Disease Patients
$682,022Diane M Becker · Johns Hopkins University · R01 · FY2009 · NR
Prospective Cohort Study of Chronic Renal Insufficiency
$682,000Akinlolu O Ojo · University Of Michigan At Ann Arbor · U01 · FY2007 · DK
Dual targeting chemokine receptors prevents chemotherapy-induced cardiotoxicity
$681,996Yi Tan · University Of Louisville · R01 · FY2025 · HL
Renin cell identity and blood pressure homeostasis
$681,956Maria L Sequeira Lopez · University Of Virginia · R01 · FY2023 · HL
Myosin Movement in Vitro-Molecular Characterization
$681,928James A Spudich · Stanford University · R01 · FY2015 · GM
A New Pacing Approach for Cardiac Conditioning and Enhanced Cardioprotection
$681,922Denice Hodgson-Zingman · University Of Iowa · R01 · FY2024 · HL
Targeting Mineralocorticoid Receptor Condensates to Optimize Donor Heart Preservation
$681,850Paul Tang · Mayo Clinic Rochester · R01 · FY2025 · HL
The Role of PRDM16 in Cardiac Development and Cardiomyopathy
$681,823Sihem Boudina · University Of Utah · R01 · FY2021 · HL
Repair and Angiogenesis by Stem Cells in Human Heart
$681,725Piero Anversa · Brigham And Women'S Hospital · R37 · FY2014 · HL
Enhanced Linkage of Drug Abusers to Primary Medical Care
$681,674Jeffrey H Samet · Boston Medical Center · R01 · FY2009 · DA
Subclinical Atherosclerosis in HIV plus Black Cocaine Users
$681,649Shenghan Lai · Johns Hopkins University · R01 · FY2011 · DA